Problem 5
Question
A 35-year-old woman with a history of migraine reports to her physician that the last time she used her medicine to stop an acute attack, she felt numbness and tingling in her extremities and blanching and cyanosis of her fingers. Which one of the following medications did she take? (A) butorphanol (B) sumatriptan (C) dihydroergotamine (D) tramadol (E) naproxen
Step-by-Step Solution
Verified Answer
The woman most likely took dihydroergotamine.
1Step 1: Understand the Symptoms
The patient experienced numbness, tingling in extremities, blanching, and cyanosis of fingers. These symptoms are consistent with vasoconstriction, which can lead to reduced blood flow to the extremities.
2Step 2: Identify Medication Effects
Different migraine medications have different mechanisms of action. Dihydroergotamine, among the options, is a vasoconstrictor and can cause symptoms of peripheral vasospasm, such as numbness, tingling, blanching, and cyanosis. Sumatriptan does cause vasoconstriction but is less likely to produce the peripheral symptoms described.
3Step 3: Eliminate Unlikely Options
Butorphanol is an opioid pain reliever and doesn't cause significant vasoconstriction. Tramadol, also a pain reliever, and naproxen, an NSAID, do not cause vasoconstriction either, nor do they typically produce these specific symptoms.
4Step 4: Conclusion on Medication
Given that dihydroergotamine is known for causing vasoconstriction resulting in symptoms like those experienced by the patient, it is the most likely medication taken in this scenario.
Key Concepts
Migraine TreatmentVasoconstrictionPeripheral VasospasmMedication Side Effects
Migraine Treatment
Migraines are severe headaches that can cause intense throbbing or a pulsing sensation. They are often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. Treatment for migraines aims to relieve symptoms and prevent future attacks.
An effective migraine treatment plan usually includes a combination of medications and lifestyle adjustments. The key is to tailor the approach to meet individual needs, as one size never fits all.
An effective migraine treatment plan usually includes a combination of medications and lifestyle adjustments. The key is to tailor the approach to meet individual needs, as one size never fits all.
- Acute treatments: These are used during a migraine attack to relieve symptoms. Common options include triptans (e.g., sumatriptan), ergotamines (e.g., dihydroergotamine), NSAIDs, and anti-nausea medications.
- Preventive treatments: These medications are taken regularly to reduce the frequency and severity of migraines. They include beta-blockers, anticonvulsants, and antidepressants.
Vasoconstriction
Vasoconstriction refers to the narrowing of blood vessels, which reduces blood flow to certain parts of the body. While it is a natural process in response to cold or stress, certain medications can induce vasoconstriction as well.
Drugs like dihydroergotamine and sumatriptan, often used in treating migraines, work by constricting blood vessels to curb migraine symptoms. However, this mechanism can sometimes lead to unpleasant side effects, particularly in peripheral areas of the body.
Understanding vasoconstriction is essential for recognizing the risk associated with certain migraine medications. This effect is why careful monitoring and consultation with a healthcare provider are needed when managing migraines with drugs that cause vasoconstriction.
Drugs like dihydroergotamine and sumatriptan, often used in treating migraines, work by constricting blood vessels to curb migraine symptoms. However, this mechanism can sometimes lead to unpleasant side effects, particularly in peripheral areas of the body.
Understanding vasoconstriction is essential for recognizing the risk associated with certain migraine medications. This effect is why careful monitoring and consultation with a healthcare provider are needed when managing migraines with drugs that cause vasoconstriction.
Peripheral Vasospasm
Peripheral vasospasm involves the sudden constriction of blood vessels in the extremities, like fingers or toes. It can cause symptoms such as numbness, tingling, pallor, and even cyanosis. These occur when the blood supply to the tissues is temporarily reduced.
Migraine medications like dihydroergotamine and sometimes sumatriptan can trigger peripheral vasospasm. Patients might experience symptoms that resemble those of Raynaud's phenomenon, a condition characterized by excessively reduced blood flow.
Individuals experiencing these symptoms after taking migraine medication should consult their physician. Adjustment of medication or using alternative treatments might be necessary to prevent such adverse effects.
Migraine medications like dihydroergotamine and sometimes sumatriptan can trigger peripheral vasospasm. Patients might experience symptoms that resemble those of Raynaud's phenomenon, a condition characterized by excessively reduced blood flow.
Individuals experiencing these symptoms after taking migraine medication should consult their physician. Adjustment of medication or using alternative treatments might be necessary to prevent such adverse effects.
Medication Side Effects
Medications can sometimes cause unwanted side effects, influencing the choice of treatment. Being informed about potential side effects is integral when considering any medication, particularly for managing conditions like migraines.
Migraine medications, especially those causing vasoconstriction such as dihydroergotamine, can have side effects ranging from mild to severe.
Migraine medications, especially those causing vasoconstriction such as dihydroergotamine, can have side effects ranging from mild to severe.
- Common side effects: These might include feelings of numbness or tingling of extremities, as noted in the case description.
- Serious side effects: Some medications might cause significant vasoconstriction leading to peripheral vasospasm, which requires immediate medical attention.
Other exercises in this chapter
Problem 3
The therapeutic effect of the triptan class of drugs is caused by which mechanism of action? (A) antagonism at serotonin 5- \(\mathrm{HT}_2\) receptors (B) stim
View solution Problem 4
Verapamil is indicated for the treatment of migraine because it has which of the following effects? (A) it prevents the release of serotonin (B) it is a \(5-\ma
View solution Problem 2
Use of sumatriptan is contraindicated in which one of the following groups of patients? (A) postpartum women (B) patients with uncontrolled hypertension (C) pat
View solution